Clinical Research in Cardiology

Papers
(The H4-Index of Clinical Research in Cardiology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry75
Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial68
Correlation of greyzone fibrosis compared to troponin T and late gadolinium enhancement with survival and ejection fraction in patients after acute myocardial infarction56
Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort55
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial47
Prognostic value of high-sensitivity cardiac troponin I after isolated non-CABG cardiac surgery44
Heart failure burden and care among cardiology inpatients: insights from the Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study44
Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry44
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysis42
Efficacy of coronary sinus reducer in patients with refractory angina and chronic total occlusion41
Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection37
Prognostic utility of a multi-biomarker panel in patients with suspected myocardial infarction36
Not obtaining a medication the first time it is prescribed: primary non-adherence to cardiovascular pharmacotherapy36
Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography35
Simultaneous transcatheter valve-in-valve replacement of severely degenerated bioprosthetic aortic and mitral prostheses35
Association of daily physical activity with pulmonary artery pressure in HFpEF and HFmrEF NYHA class III patients: a pilot trial—feasibility and first results33
Rebuttal to: “Comment on the CORRECT RADIAL trial: considerations on methodology and interpretation.“ (CRCD-D-26–00099)31
Clinical characteristics and etiology-specific outcome in pediatric hypertrophic cardiomyopathy30
Collagen type I degradation peptide as a predictive biomarker for mortality in ST-elevated myocardial infarction30
Venting during venoarterial extracorporeal membrane oxygenation29
Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy28
Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registry27
10-year follow-up of interventional electrophysiology: updated German survey during the COVID-19 pandemic27
HI-PLUS: design of a cluster-randomized trial evaluating structured case management with telemonitoring to improve quality of life in heart failure27
Heterogeneity of outcomes within diabetic patients with atrial fibrillation on edoxaban: a sub-analysis from the ETNA-AF Europe registry25
Appointment as Editor-in-Chief of Clinical Research in Cardiology—goals and vision25
The effect of a smaller spacer in the PASCAL Ace on residual mitral valve orifice area25
Antithrombotic strategy following valve-in-valve transcatheter aortic valve replacement. A German Statutory Health Claims data analysis25
0.12583994865417